Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.8%

4 terminated/withdrawn out of 217 trials

Success Rate

96.4%

+9.9% vs industry average

Late-Stage Pipeline

18%

40 trials in Phase 3/4

Results Transparency

8%

8 of 106 completed trials have results

Key Signals

51 recruiting8 with results

Enrollment Performance

Analytics

N/A
109(59.6%)
Phase 3
24(13.1%)
Phase 2
21(11.5%)
Phase 4
16(8.7%)
Phase 1
11(6.0%)
Early Phase 1
2(1.1%)
183Total
N/A(109)
Phase 3(24)
Phase 2(21)
Phase 4(16)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (217)

Showing 20 of 217 trials
NCT05137119Phase 4Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial

Role: lead

NCT05105633Phase 2Recruiting

Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke

Role: lead

NCT05203224Phase 2Completed

Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)

Role: lead

NCT07055542Not ApplicableRecruiting

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Role: lead

NCT06940596Not ApplicableRecruiting

Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?

Role: lead

NCT06898853Not ApplicableRecruiting

The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes

Role: collaborator

NCT06965751Phase 1Active Not Recruiting

A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19

Role: lead

NCT05204550Phase 2Completed

Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

Role: collaborator

NCT06972810Not ApplicableCompleted

Human Infection Study of H3N2 Influenza in Healthy Adults

Role: lead

NCT07019493Recruiting

Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke

Role: collaborator

NCT06510699Phase 2Recruiting

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

Role: collaborator

NCT06650501Phase 4Recruiting

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Role: collaborator

NCT06992141Early Phase 1Completed

A Strep Throat Controlled Human Infection Trial in Healthy Adults

Role: collaborator

NCT07468526Phase 3Not Yet Recruiting

An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria

Role: collaborator

NCT07468513Phase 4Recruiting

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

Role: collaborator

NCT06325202Not ApplicableRecruiting

Closed Loop and Education for Hypoglycemia Awareness Restoration

Role: collaborator

NCT07416292Recruiting

ListenFuture-Listening for Their Future: Deaf and Hard-of-Hearing Adolescents

Role: collaborator

NCT06637332Phase 4Recruiting

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Role: collaborator

NCT07434180Phase 2Not Yet Recruiting

Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary

Role: collaborator

NCT07293455Not ApplicableNot Yet Recruiting

Evaluation and Demonstration of New Tuberculosis Diagnostics for Indonesia

Role: collaborator